Here are some things to consider, including a discussion with your healthcare team, before you mix booze and a GLP-1 medication
But not through the mechanism most marketing claims suggest
Stephanie Weiss, M.D., Ph.D., assistant director for the Clinical Research, Medication Development Program at NIDA, shared data from the first published clinical trial of GLP-1 RAs in alcohol use disorder: in patients with obesity with a BMI over 30, exenatide reduced heavy drinking days by 23.6% and lowered total alcohol intake
L-Carnitine and the Heart [Stephen T
GHK-Cu Injection Reactions to Watch For Any injection can cause local discomfort, redness, bruising, swelling, itching, or a small lump
Your doctor may also notice a difference if they process lab results